Triple or Dual Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry
Latest Information Update: 05 Oct 2022
At a glance
- Drugs Acenocoumarol (Primary) ; Apixaban (Primary) ; Clopidogrel (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Prasugrel (Primary) ; Rivaroxaban (Primary) ; Ticagrelor (Primary) ; Warfarin (Primary)
- Indications Myocardial infarction; Thrombosis
- Focus Therapeutic Use
- Acronyms TRIDUAL-PCI
- 06 Mar 2020 New trial record